Skip to main content
Article thumbnail
Location of Repository

Identification of a Cytokine-induced Antiapoptotic Molecule Anamorsin Essential for Definitive Hematopoiesis

By Hirohiko Shibayama, Emi Takai, Itaru Matsumura, Michiyoshi Kouno, Eiichi Morii, Yukihiko Kitamura, Junji Takeda and Yuzuru Kanakura


Many growth factors and cytokines prevent apoptosis. Using an expression cloning method, we identified a novel antiapoptotic molecule named Anamorsin, which does not show any homology to known apoptosis regulatory molecules such as Bcl-2 family, caspase family, or signal transduction molecules. The expression of Anamorsin was completely dependent on stimulation with growth factors such as interleukin 3, stem cell factor, and thrombopoietin in factor-dependent hematopoietic cell lines, and forced expression of Anamorsin conferred resistance to apoptosis caused by growth factor deprivation in vitro. Furthermore, Anamorsin was found to act as an antiapoptotic molecule in vivo because Anamorsin−/− mice die in late gestation due to defective definitive hematopoiesis in the fetal liver (FL). Although the number of hematopoietic stem/progenitor cells in the FL did not decrease in these mice, myeloid, and particularly erythroid colony formation in response to cytokines, was severely disrupted. Also, Anamorsin−/− erythroid cells initiated apoptosis during terminal maturation. As for the mechanism of Anamorsin-mediated cell survival, a microarray analysis revealed that the expression of Bcl-xL and Jak2 was severely impaired in the FL of Anamorsin−/− mice. Thus, Anamorsin is considered to be a necessary molecule for hematopoiesis that mediates antiapoptotic effects of various cytokines

Topics: Article
Publisher: The Rockefeller University Press
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1991). A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis.
  2. (1995). Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/SCL.
  3. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coativator core binding factor .
  4. (1996). AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.
  5. (1994). An early haematopoietic defect in mice lacking the transcription factor GATA-2.
  6. (1994). Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis.
  7. (2000). Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation. Genes Dev.
  8. (2001). Apoptosis suppression by Raf-1 and MEK1 requires MEKand phosphatidylinositol 3-kinase-dependent signals.
  9. (1999). Cellular survival: a play in three Akts. Genes Dev.
  10. (1998). Critical role of the Tie2 endothelial cell receptor in the development of definitive hematopoiesis.
  11. (1999). Cytokine signaling for proliferation, survival, and death in hematopoietic cells.
  12. (2000). Cytokines and their receptors in cardiovascular diseases-role of gp130 signaling pathway in cardiac myocyte growth and maintenance.
  13. (1995). Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene.
  14. (1995). Efficient screening of retroviral cDNA expression libraries.
  15. (1991). Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1.
  16. (1998). Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. Genes Dev.
  17. (1999). Fetal anemia and apoptosis of red cell progenitors
  18. (2000). Full oncogenic activities of v-Src are mediated by multiple signaling pathways.
  19. Functional cooperation among Ras, STAT5, and phosphatidylinositol 3-kinase is required for full oncogenic activities of BCR/ABL in K562 cells.
  20. (1995). Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor.
  21. (2001). Growth factor signaling in cell survival: implications for cancer treatment.
  22. (1996). Growth factors in skeletal muscle regeneration. Cytokine Growth Factor Rev.
  23. (1999). H-Ras is involved in the insideout signaling pathway of interleukin-3-induced integrin activation.
  24. (1998). Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation.
  25. Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer.
  26. (2001). Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation.
  27. (1998). Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis.
  28. (1995). Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice.
  29. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization.
  30. (1994). Monoclonal antibodies distinctively recognizing the subtypes of inositol 1, 4, 5-trisphosphate receptor: application to the studies on inflammatory cells.
  31. (1995). Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor.
  32. (1999). Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity.
  33. (1998). Qualitative and quantitative aspects of haematopoietic cell development in the mammalian embryo.
  34. (1995). Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells.
  35. (1997). requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis.
  36. (2000). Requirement for p38 in erythropoietin expression: a role for stress kinases in erythropoiesis.
  37. (2001). Requirement of DNaseII for definitive erythropoiesis in the mouse fetal liver.
  38. (2000). Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
  39. (1997). Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes.
  40. (1997). Stem cell factor and hematopoiesis.
  41. Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis.
  42. (2000). The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage.
  43. (1994). The oncogenic cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development.
  44. (2003). The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev.
  45. (2002). Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways.
  46. (1999). Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.